RECRUITING

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Official Title

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

Quick Facts

Study Start:2020-07-09
Study Completion:2030-12-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04684602

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 and older
  2. * Ability to provide informed consent
  3. * Availability for follow up visits
  1. * Active or recent malignancy (within last 2 years)
  2. * Pregnancy or breast-feeding
  3. * Inability to provide informed consent

Contacts and Locations

Study Contact

Paul C Bogaardt, PhD(c), MSc, MBA
CONTACT
866 864 7789
paul@thomasadvancedmedical.com
Karen Mulholland Angelus
CONTACT
866 864 7789
karen@thomasadvancedmedical.com

Principal Investigator

Ernst R Von Schwarz, MD, PhD
PRINCIPAL_INVESTIGATOR
HeartStem Institute, Southern California Hospital at Culver City

Study Locations (Sites)

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, California, 92032
United States

Collaborators and Investigators

Sponsor: Thomas Advanced Medical LLC

  • Ernst R Von Schwarz, MD, PhD, PRINCIPAL_INVESTIGATOR, HeartStem Institute, Southern California Hospital at Culver City

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-07-09
Study Completion Date2030-12-09

Study Record Updates

Study Start Date2020-07-09
Study Completion Date2030-12-09

Terms related to this study

Keywords Provided by Researchers

  • stem cell therapy
  • umbilical cord stem cells
  • amniotic stem cells
  • stem cells
  • MSC
  • Mesenchymal Stem Cell
  • Medicinal Signaling Cell
  • Erectile Dysfunction
  • Heart Diseases
  • Mental Disorders
  • Neurocognitive Disorders
  • Neurodegenerative Diseases
  • Central Nervous System Diseases
  • Tauopathies
  • Brain Diseases
  • Dementia
  • Disease
  • Cardiomyopathies
  • Urologic Diseases
  • Peripheral Nervous System Diseases
  • Nervous System Diseases
  • Alzheimer Disease
  • Musculoskeletal Diseases
  • Cardiovascular Diseases
  • Immune System Diseases
  • Neuromuscular Diseases
  • Covid-19

Additional Relevant MeSH Terms

  • Autoimmune Diseases
  • Cardiovascular Disorders
  • Diabetes Complications
  • Integumentary Disease
  • Musculoskeletal Disorders
  • Neurodegenerative Disorders
  • Neurologic Disorders
  • Pulmonary Disorders
  • Sexual Dysfunction
  • Urologic Disorders
  • Viral Illness